Fully financed Phase III program for Mangoral through the IPO

Booking.com

Ascelia Pharma AB (publ) (ticker: ACE) today announced that its interim report for the period January-March 2019 is now available on the company’s website: https://www.ascelia.com/tag/reports-presentations/
IMPORTANT EVENTS IN THE PERIOD

· IPO of SEK 200 million
· More than 6,000 new shareholders in the IPO – both institutional and private
· Fully financed Phase III program for Mangoral

IMPORTANT EVENTS AFTER THE PERIOD

Booking.com

· Encouraging results from Oncoral’s Phase I combination study with oral capecitabine
· IPO overallotment utilised raising SEK 22 million
·

Source: Fully financed Phase III program for Mangoral through the IPO

Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.